CAN-FITE BIOPHARMA LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.7 ILa | 0.00% |
|
-3.57% | +3.85% |
| 05-12 | Transcript : Can-Fite BioPharma Ltd. - Special Call | |
| 05-09 | Can-Fite BioPharma Ltd. Announces FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study | CI |
3400.I1b3OhpV8N47ziEaQkN9KjcFFr7pQSrfCVToj5hU-RM.RBmaeyMNhe1ylBZtFDtOawFsb8-cMm6mbyWF7K4Dj2RqNZ95TgfCukz9Vg~2a3cb130a4a8254b4388d39b3378055a
